| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:(-)-5'-DMH-CBD;5-(1,1-DiMethylheptyl)-2-[(1R,6R)-3-Methyl-6-(1-Methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol
CAS:97452-63-6
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
EMMX Biotechnology LLC
|
| Tel: |
888-539-0666 |
| Email: |
info@emmx.com |
| Products Intro: |
Product Name:(-)-5'-DMH-CBD
CAS:97452-63-6
Purity:98% HPLC Package:5mg;10mg;25mg;50mg;100mg;250mg;500mg;1g
|
| Company Name: |
Shanghai Hongye Biotechnology Co. Ltd
|
| Tel: |
400-9205774 |
| Email: |
sales@glpbio.cn |
| Products Intro: |
Product Name:(-)-5’-DMH-CBD
CAS:97452-63-6
Purity:>98% Package:1mg;10mg;50mg;100mg;
|
|
| | (-)-5'-DMH-CBD Basic information |
| Product Name: | (-)-5'-DMH-CBD | | Synonyms: | (-)-5'-DMH-CBD;5-(1,1-DIMETHYLHEPTYL)-2-[(1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL]-1,3-BENZENEDIOL;5-(1,1-dimethylheptyl)cannabidiol;5-(1,1-Dimethylheptyl)-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzendiol;-DMH-CBD;HU 219;1,3-Benzenediol, 5-(1,1-dimethylheptyl)-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-;CBD-DMH | | CAS: | 97452-63-6 | | MF: | C25H38O2 | | MW: | 370.57 | | EINECS: | | | Product Categories: | Cannabinoid receptor | | Mol File: | 97452-63-6.mol |  |
| | (-)-5'-DMH-CBD Chemical Properties |
| Boiling point | 502.1±50.0 °C(Predicted) | | density | 0.992±0.06 g/cm3(Predicted) | | storage temp. | Desiccate at -20°C | | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | | pka | 9.56±0.45(Predicted) | | form | Oil to Gel | | color | Light Yellow to Brown |
| | (-)-5'-DMH-CBD Usage And Synthesis |
| Uses | (-)-5'-DMH-CBD is a useful research chemical.(-)-5'-DMH-CBD represents a valuable candidate for further investigation as inhibitor of AEA uptake and a possible new therapeutic agent. | | Biological Activity | Anandamide membrane transport inhibitor (IC 50 = 14 μ M) that is relatively metabolically stable. Displays some affinity for CB 2 receptors but has only weak affinity for CB 1 receptors and has no activity at VR1 receptors or FAAH. Anticonvulsive in vivo following systemic administration. |
| | (-)-5'-DMH-CBD Preparation Products And Raw materials |
|